Table 2 PAM50 ROR score (ROR-S) risk classification and 10-year DRFI by DGM and RI-DR scores.

From: A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients

PAM50 ROR-S

DGM-low 10-year DRFI

DGM-high 10-year DRFI

Log-rank p-value

Patient #

% (95% CI)

Patient #

% (95% CI)

Low

169

93.5% (86.3%, 97.0%)

26

77.1% (53.1%, 89.9%)

0.0019

Intermediate

83

95.7% (87.1%, 98.6%)

113

88.8% (81.0%, 93.5%)

0.0831

High

21

64.1% (33.6%, 83.4%)

340

85.2% (80.6%, 88.8%)

0.0883

 

RI-DR low 10-year DRFI

RI-DR high 10-year DRFI

 

Low

151

94.6% (86.7%, 97.8%)

44

80.5% (62.9%, 90.3%)

0.0016

Intermediate

66

98.5% (89.6%, 99.8%)

130

88.5% (81.3%, 93.0%)

0.0263

High

15

77.4% (31.5%, 94.5%)

346

84.2% (79.5%, 87.9%)

0.8150